Nourkrin® is committed to ensuring its recognition as a benchmark for excellence – not only by consumers, but also by scientists, dermatologists, cosmetologists and aestheticians worldwide.
Nourkrin® is based on more than 56 scientific studies and clinical papers published in leading peer-review journals.
Nourkrin® has been tested in placebo, double-blind studies and shown to be side effect free.* This is in contrast to other pharmaceuticals, which may cause; scalp itching, dryness, scaling, flaking, irritation, burning and in extreme instances weight gain, swelling of the face, ankles, hands or stomach, difficulty breathing (especially when lying down), rapid heartbeat, chest pain and light headedness.**
Nourkrin® continues to partner with the world’s leading authorities on hair loss and hair thinning based on its clinically documented efficacy and safety standards.
Nourkrin® contains naturally based ingredients that have been scientifically documented to be safe and effective.*
*Thom E. Nourkrin®: Objective and Subjective Effects and Tolerability in Persons with Hair Loss. J Int Med Res. 2006;34(5):514-9.
Kingsley DH, Thom E. Cosmetic Hair Treatments Improve Quality of Life in Women with Female Pattern Hair Loss. J Appl Cosmetol. 2012;30:49-59.
Thom E, Wadstein J, Thom EW, Kingsley DH. Treatment of Hair Thinning and Hair Ageing with Specific Lectican and Leucine Proteoglycans. A Review. J Appl Cosmetol. 2014;32:105-15.
Thom E. Stress and the Hair Growth Cycle: Cortisol-Induced Hair Growth Disruption. J Drugs Dermatol. 2016;15(8):1001-4.
Thom E. Pregnancy and the Hair Growth Cycle: Anagen Induction against Hair Growth Disruption using Nourkrin® with Marilex®, a Proteoglycan Replacement Therapy. J Cosmet Dermatol. 2017;16(3):421-7.
Thom E, Thom EW. Lifestyle Diseases and the Hair Growth Cycle: A Multidisciplinary Approach using Nourkrin® with Marilex®, a Proteoglycan Replacement Therapy, for Anagen Induction and Maintenance. Ann Dermatol Res. 2017;1:6-11.
Thom E, Wadstein J, Kingsley DH, Thom EW. Metabolic Syndrome, Cardiovascular Disease and the Hair Growth Cycle: Addressing Hair Growth Disruptions using Nourkrin® with Marilex® as a Proteoglycan Replacement Therapy. A Concise Review. Ann Dermatol Res. 2018;2:1-7.
**Studies about finastride: Kaufman KD, Olsen EA, Whiting D, Savin R, DeVillez R, Bergfeld W, et al. Finastride in the treatment of men with androgenetic alopecia. J Am Acad Dermatol .1998;39:578-89 & Leyden J, Dunlap F, Miller B, Winters P, Lebwohl M, Hecker D, et al. Finasteride in the treatment of men with frontal male pattern hair loss. J Am Acad Dermatol.1999;40;930-7.